These data indicated that the mTORC1-STAT3-FGFBP1 signaling pathway plays a crucial role in angiogenesis in chronic asthma, and rapamycin treatment can block the progression of angiogenesis in the airway wall. Here, FGFBP1 is linked to chronic asthma.